Tariff Notices · Tariffs · confirmed
UK patented-pharma Section 232 rate falls from 10% to 0%
Updated · Impact score 74/100 · Confidence 55%
Commerce reduced the additional tariff on covered patented pharmaceutical articles and associated ingredients that are products of the United Kingdom from 10% to 0%. CBP says the change applies under HTSUS 9903.04.63 to entries and warehouse withdrawals from 12:01 a.m. Eastern Time on July 31 and that ACE is updated.
Why it matters
The reduction directly changes entry treatment for covered UK-origin pharmaceuticals, but it does not make every pharmaceutical product duty-free. Importers still need the Chapter 1–97 classification, the definitions in U.S. note 40, and the applicable Chapter 99 reporting sequence.
What to check next
Map UK-origin patented pharmaceuticals and associated ingredients to CBP's Chapter 1–97 list and U.S. note 40, report HTSUS 9903.04.63 at the 0% additional rate for qualifying entries from July 31, and review entries filed since the effective time for any incorrect 10% assessment that should be raised with your broker or CBP.
Affected entities
- United Kingdom -> US
- HTSUS 9903.04.63 — 0% additional Section 232 rate for qualifying UK patented pharmaceuticals
- Commerce/BIS
- CBP
- Patented pharmaceuticals
- Associated pharmaceutical ingredients
- Section 232 tariffs